Loading organizations...
§ Private Profile · Galway, Galway, Ireland
Clinical-stage medical device company develops transcatheter tricuspid valve repair for interventional cardiology, treating tricuspid regurgitation.
4Tech is a clinical-stage medical device company based in Galway, Ireland, that develops the TriCinch System for transcatheter tricuspid valve repair. The organization focuses exclusively on minimally invasive treatments for structural heart disease, specifically targeting patients and clinicians managing tricuspid regurgitation. Operating with an additional facility in Waltham, Massachusetts, the firm advances its proprietary technology through international clinical trials and interventional cardiology applications. To support these research and commercialization efforts, the enterprise secured a $29 million Series B funding round in 2015 backed by institutional investors including Valiance, NeoMed Management, and LivaNova. The company completed its first United States implantations in 2018 and operates under a leadership team that includes Chief Executive Officer Michael Ennen and Chairman Bill Hawkins, the former CEO of Medtronic. 4Tech was founded in 2011 by Carine Schorochoff.
4Tech has raised $29.0M across 1 funding round.
4Tech has raised $29.0M in total across 1 funding round.
4Tech has raised $29.0M in total across 1 funding round.
4Tech's investors include RMM, Jan Pensaert, NeoMed Management.
4Tech has raised $29.0M across 1 funding round. Most recently, it raised $29.0M Series B in March 2016.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 9, 2016 | $29M Series B | RMM, JAN Pensaert | Neomed Management | Announced |